Cargando…
NaCT/SLC13A5 facilitates citrate import and metabolism under nutrient-limited conditions
Citrate lies at a critical node of metabolism, linking tricarboxylic acid metabolism and lipogenesis via acetyl-coenzyme A. Recent studies have observed that deficiency of the sodium-dependent citrate transporter (NaCT), encoded by SLC13A5, dysregulates hepatic metabolism and drives pediatric epilep...
Autores principales: | Kumar, Avi, Cordes, Thekla, Thalacker-Mercer, Anna E., Pajor, Ana M., Murphy, Anne N., Metallo, Christian M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8500708/ https://www.ncbi.nlm.nih.gov/pubmed/34525352 http://dx.doi.org/10.1016/j.celrep.2021.109701 |
Ejemplares similares
-
Discovery and characterization of novel inhibitors of the sodium-coupled citrate transporter (NaCT or SLC13A5)
por: Huard, Kim, et al.
Publicado: (2015) -
Structure and inhibition mechanism of the human citrate transporter NaCT
por: Sauer, David B., et al.
Publicado: (2021) -
The Hepatic Plasma Membrane Citrate Transporter NaCT (SLC13A5) as a Molecular Target for Metformin
por: Kopel, Jonathan, et al.
Publicado: (2020) -
Functional analysis of a species-specific inhibitor selective for human Na(+)-coupled citrate transporter (NaCT/SLC13A5/mINDY)
por: Higuchi, Kei, et al.
Publicado: (2020) -
Model‐Based Assessment of Plasma Citrate Flux Into the Liver: Implications for NaCT as a Therapeutic Target
por: Li, Z, et al.
Publicado: (2016)